Have a personal or library account? Click to login
Paeoniflorin inhibits the growth of bladder carcinoma via deactivation of STAT3 Cover

Paeoniflorin inhibits the growth of bladder carcinoma via deactivation of STAT3

Acta Pharmaceutica
Volume 68 (2018): Issue 2 (June 2018)
By: Jianhui Yang,  Yu Ren,  Zhong-Guan Lou,  Xue Wan,  Guo-Bin Weng and  Dong Cen  
Open Access
|Apr 2018

Authors

Jianhui Yang

Laboratory of Kidney Carcinoma, Ningbo Urology and Nephrology Hospital, Urology and Nephrology Institute of Ningbo University, Ningbo

Yu Ren

Laboratory of Kidney Carcinoma, Ningbo Urology and Nephrology Hospital, Urology and Nephrology Institute of Ningbo University, Ningbo

Zhong-Guan Lou

Laboratory of Kidney Carcinoma, Ningbo Urology and Nephrology Hospital, Urology and Nephrology Institute of Ningbo University, Ningbo

Xue Wan

Laboratory of Kidney Carcinoma, Ningbo Urology and Nephrology Hospital, Urology and Nephrology Institute of Ningbo University, Ningbo

Guo-Bin Weng

wgbningbo@126.com

Laboratory of Kidney Carcinoma, Ningbo Urology and Nephrology Hospital, Urology and Nephrology Institute of Ningbo University, Ningbo

Dong Cen

cengdong2002@163.com

Laboratory of Kidney Carcinoma, Ningbo Urology and Nephrology Hospital, Urology and Nephrology Institute of Ningbo University, Ningbo
DOI: https://doi.org/10.2478/acph-2018-0013 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 211 - 222
Accepted on: Dec 20, 2017
Published on: Apr 26, 2018
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
bladder cancer,
Radix Paeoniae alba,
paeoniflorin,
apoptosis,
STAT3
Related subjects:
Pharmacy,
Pharmacy, other

© 2018 Jianhui Yang, Yu Ren, Zhong-Guan Lou, Xue Wan, Guo-Bin Weng, Dong Cen, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 68 (2018): Issue 2 (June 2018)Next article